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Abstract 
In a prospective study, 102 hospital patients with liver disease were evaluated in West Cameroon, Africa. 
Blood donors, pregnant women and patients without liver disease served as controls. A total of 757 individ- 
uals were tested for markers of hepatitis A, B, C and D and for immunological markers (autoantibodies, 
procollagen III, a-foetoprotein, CA50 antigen, or-1-antitrypsin and antibodies to human immunodeficiency 
virus types 1 and 2). One-third of the liver disease patients had focal lesions on ultrasound examination. His- 
tologically, 20 cases of cirrhosis, 14 cases of chronic hepatitis, 15 hepatocellular carcinomas and 17 cases of 
acute hepatitis were detected. All hepatic patients and virtually all controls had had a previous hepatitis A 
virus infection. Over 85% of adult patients and controls had at least one marker of hepatitis B virus infec- 
tion. Over 30% of patients with liver disease had markers of possible hepatitis B virus replication. Anti- 
hepatitis C virus antibody was present in 18% of hepatic patients and in 6% of controls. Hepatitis C virus 
infection seems to play an important role in the development of chronic liver pathology; 40% of cirrhotic 
patients had a combined hepatitis B and C virus infection, Serum autoantibodies were frequently found and 
were not correlated with the presence of autoimmune liver disease. 
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Introduction 
Data on liver pathology and hepatitis virus serology 
from rural tropical Africa are scarce. Being impressed by 
the frequency of liver diseases in patients at the Man- 
yemen General Hospital in the South-West Province of 
Cameroon, we conducted a prospective study to eluci- 
date the nature, aetiology and diagnostic management of 
liver disease in hospital patients during a period of 2 
years. 
The study included a standardized clinical investiga- 
tion, ultrasound examination, liver function tests, liver 
histology, hepatitis virus and human immunodeficiency 
virus (HIV) serology, and the determination of several 
autoantibodies and immunological markers. Blood 
donors! pregnant women and patients with minor 
complamts not related to the liver served as controls. 
Manyemen is situated in the rural, tropical forest area 
of the South-West Province of Cameroon. The Presbyte- 
rian General Hospital at Manyemen has 115 beds and a 
large primary health care service and serves a population 
of about 250 000 in a area of 15 000 km2. Falciparum 
malaria and filarial infections are hyperendemic, whereas 
parasites invading the liver, such as Schistosoma mansoni 
and liver flukes, are rare. 
Study design and Methods 
We investigated 102 consecutive patients from Sep- 
tember 1990 to August 1992. Inclusion criteria were 
clinically suspected liver disease on grounds of jaundice, 
ascites, right upper quadrant pain or a pathological liver 
mass. Initially 135 patients were enrolled, but 33 had to 
be excluded because of incomplete data, erroneous 
diagnosis or pathological conditions not permitting liver 
biopsy. 
For the history, clinical examination and abdominal 
ultrasound standardized questionnaires and record forms 
were used. Ultrasound examination was performed using 
a Siemens Sonoline@ 1300 linear scanner of 3 MHz. 
Liver biopsy was either performed ‘blindly’ according to 
the Menghini technique or under laparoscopic ontrol. 
The bioDsv soecimens were kew in 10% formalin and 
later examined by one of us (L.B:). 
Basic laboratory determinations were performed ac- 
cording to the World Health Organization recommend- 
ations (WHO, 1980); liver function tests were performed 
with the aid of a Boehringer Reflotron-Photometer@. 
For immunological investigations, sera were stored at 
-4°C and later analysed at the Section of Clinical Immu- 
nology of the University Hospital, Zurich, Switzerland. 
Address for correspondence: Dr med. J. Skalsky, Unterdorf- 
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Markers of hepatitis A, B, C and D viruses (HAV, HBV, 
HCV, HDV) and autoantibodies such as anti-nuclear 
antibodies (ANA), anti-mitochondrial antibodies 
(AMA), and anti-smooth muscle antibodies (ASM) were 
determined by indirect immunofluorescence, anti-M2 
antibodies (AM2) by an anti-M2 enzyme-linked immuno- 
sorbent assay (ELBA) (Elias, Freiburg, Germany), pro- 
collagen III by P III-peptide radio-immunoassay (RIA) 
(Boehring, Marburg, Germany), and a-1-antitrypsin 
with the aid of a BNA-Nephelometer-Analizera (Boehr- 
ing, Marburg, Germany). HIV-l and HIV-2 antibodies 
were also investigated, using commercial screening test 
kits and following the procedures recommended by the 
manufacturers (Abbott Laboratories, North Chicago, Il- 
linois, USA). HIV-l and HIV-2 antibodies were deter- 
mined with the Abbott recombinant HIV-l and HIV-2 
enzyme immunoassay. Confirmation was by Western 
blotting for HIV-l (Du Pont, USA) and HIV-2 (Pasteur, 
France). Anti-HCV was measured by a second gener- 
ation ELBA (Ortho Diagnostic), positive results being 
confirmed by the Chiryon recombinant immunoblot 
assay second generation HCV test (Chiryon Corporation, 
USA). 
Results 
The 102 patients with liver disease consisted of 67 
males and 35 females, age range 6 months to 80 years 
imean 40.5f 19 vears): 64 of 95 eave a historv of regular 
alcohol intake (hair& industrii beers and’local ialm 
wine), 7 of 64 reported a blood transfusion, 24 of 60 re- 
ported a previous episode of jaundice, and 41 of 53 had 
taken traditional herbal medicines. 
Clincialpresentation 
The 5 most frequently encountered clinical presenta- 
tions among 102 patients were jaundice (related to liver 
disease), 31; right upper quadrant pains, 20; ascites, 17; 
right upper quadrant umour, 16; and hepatomegaly, 15. 
Abdominal ultrasound examination 
Focal lesions such as abscesses, tumors or metastases 
were found in 34 of the 98 patients examined. Sterile, 
chocolate-coloured pus could be aspirated in 5 instances. 
Differentiation between amoebic liver abscess, hepatocel- 
lular carcinoma (HCC) and malignant lymphoma or 
metastases was difficult. Puncture and aspiration with a 
0.9 mmx70 mm Luer needle was safe and helpful in 
these cases; no complication occurred. 
Liver function tests 
Liver function tests were performed on 93 patients 
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with liver disease. y-Glutamyltransferase (y-glutamyl- 
transpeptidase, EC 2.3.2.2) was elevated in 67%, aspar- 
tate aminotransferase (glutamic-oxalacetic transaminase, 
EC 2.6.1.1) in 57% and alanine aminotransferase (glu- 
tamic-pyruvic transaminase, EC 2.6.1.2) in45%. 
Bleeding and coagulation times, determined by the 
Duke/Lee and White methods (WHO, 1980) were nor- 
mal in all except 3 patients, in whom there was no histo- 
logical proof of severe, diffuse liver disease. 
Table 3. Prevalence of serum markers of viral hepatitis, HIV and 
syphilis in different populations 
Patients Patients 
$$t::t Blood 
with Patiti~ts with 
minor liver 
women donors complaints HIV-1 disease 
Total no. 
!2Ees 
Age (years)a 
383 108 93 
383 
:: 
:i :?I 
2 
44 53 
(173148) $55) (O%O) (2%) (,“P;_“80) 
Histology 
Histological diagnoses were made for 98 patients 
(Table 1). Of the 20 patients with liver cirrhosis, 8 had a 
Percentages with th%El8l 
HAV (IgG) 
;f’A@W ;:i 
Table 1. Histological diagnoses for 98 hospital patients 
in Cameroona 
Anti-HBs 61.0 
Ant/-HBc (IgG) 8Li4 
$;m-fk only 
nd 
Liver cirrhosis 
Macronodular 
Micronodular 
Unspecified 
Acute heuatitis 
20 
: 
12 
17 
Viral * 
Unspecified 
Non-s ecific reactive 
Specia forms (giant cell) 3 
Hepatocellular carcinoma 
Chronic hepatitis 
Chronic active hepatitis 
Chronic persistent hepatitis 
Granulomatous hepatitis 
Secondary biliary inflammation 
Liver fibrosis 
Amoebic liver abscess 
Alcoholic liver disease 
Tropical splenomegaly syndrome 
: 
11 
2 
15 
Others 14 
Burkitt’s lymphoma 
Metastatic liver disease (adenocarcinoma) : 
Haemosiderosis 2 
Liver anor+alies (Caroli syndrome, cysts) 
Fatty liver ; 
Inconclusive histological diagnosis 
HELLP syndrome (combined diagnosis) : 
aOccasionally 2diagnoses were recorded for one patient. 
bSteatosis as the main histological finding. 
concomitant HCC, and 7 patients had HCC in a non-cir- 
rhotic liver. There was a positive correlation between 
concomitant cirrhosis and HCC (x2= 11.82; P=O.O0059) 
(Table 2). Malaria pigment was seen in nearly all the his- 
tological specimens. 
Table 2. Association between hepatocellular 
carcinoma and liver cirrhosis 
Liver cirrhosis 
Present 
EE? 
Hepatocellular carcinoma 
No. of patients Present Absent 
12 
3: ; 
98 15 ii: 
Serological markers of viral hepatitis and HIV 
The results are summarized in Table 3 and the Figure. 
All patients with liver disease and virtually all controls 
had had a previous infection with HAV; 25% of the 
healthy children up to 1 year old, and 90% of those up to 
15 years old, who were tested, had anti-HAV antibodies. 
About 90% of all the liver disease patients, blood donors 
and pregnant women had a marker of HBV infection. 
Significantly more pregnant women and blood donors 
were positive for anti-hepatitis B surface antigen anti- 
Anti-HBe 
~;;(I@3 
HIV-l 
HIV-2 
RPR’ 
nd 
6.1 
0 
2.9 
1t.0 
Iwing markersb 
96.4 77.7 
0 nd 
9.8 6.5 
55.8 38.0 
90.1 54.6 
nd nd nd 
nd nd nd 
nd nd nd 
6.4 4.7 5.4 
0 0 nd 
2.3 1.8 100 
0 0 0 
nd nd nd 
97.5 
0 
9.1 
58.2 
86.3 
100.0 
4.0 
31.4 
32.6 
g:; 
18.5 
35.2 
18.4 
::; 
0 
nd 
aMean (range in parentheses). 
‘nd=Not determined. 
‘Rapid plasma reagin test for syphilis; other abbreviations re defined in 
the text. 
body (anti-HBs) than patients, the converse being true 
for the antigen itself (HBsAg). About 10% of children up 
to 5 years old were anti-HBs positive, as were about 40% 
of those aged 15 years. The corresponding figures for 
anti-hepatitis B core antigen (anti-HBc) immunoglobulin 
G (IgG) were even higher, 30% and 57% respectively. 
0-f 25 s-15 16-25 a25 
Age group (years) 
Figure. Age distribution of hepatitis markers in hospital patients with 
minor complaints unrelated to liver disease, Cameroon, 199&1992. Dark 
grey bars: anti-hepatitis A IgG; light grey bars: anti-hepatitis B core 
antigen IgG; black bars: anti-hepatitis C IgG. 
Among patients with liver disease, markers of possible 
HBV replication were positive in a high proportion: 
HbsAg in 31%, hepatitis B e-antigen (HBeAg) in 18%, 
and anti-HBc (alone) in 31%. 
Anti-HDV was found in only 2% of patients with liver 
disease, but anti-HCV was significantly more common in 
such patients than in controls (18% versus 6%; 
PcO.025). Because of the inclusion of children, patients 
with minor complaints not related to liver disease had a 
somewhat lower infection rate with HAV, HBV and 
HCV than the control patients, including the prevalence 
of HBsAg and anti-HBs. 
The prevalence rate of anti-HIV-l among both con- 
trols and liver disease patients was low, averaging 2%. 
Immunological markers 
The results are summarized in Tables 4 and 5. Procol- 
lagen III was elevated in approximately 75% of young 
people, 63% of blood donors and 53% of liver disease pa- 
tients. CA50 antigen was elevated in more liver disease 
patients than in blood donors, but was also present in 
38% of children up to 5 years old. Anti-nuclear anti- 
bodies (ANA) were found in 75% of liver patients but 
also in 25-35% of controls and youngsters. In 13 liver 
disease patients the titres were >1:320. AMA and AM2 
were found in 22% of liver patients, the corresponding 
figures for blood donors being 5% and 16% respectively. 
In none of these patients with ANA or AMA could a 
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Table 4. Prevalence of immunological markers in patients with minor complaints, not related to liver disease in 
different age groups 
Age group (years) O-l 2-5 6-15 16-25 >25 
Total no. 19 13 26 15 35 
Females 14 3 13 13 
Males 
Mean age (years) 0.: 31,” 
Patients with the following marker? 
91: 
; 
20.3 342-72 
;$~A~GW ; ;1;:y 
Anti-HBs 
t j 
1(7.7$ 
2; y$P, 
t 
10 (38.5;) 
l; Y) r 
3: ;y;opj 
t 
Anti-HBc IgG 
;g; (Id? 
“; ~;p;q’ 
18 (51.4;) 
0 
HIV-1 ;I 
00 0 1 -) 
I 2 (-) 
{I 
0 0 c--j 
{I i 
0 
;I !! 
PI11 15 (78.9%) 
(-) 
10 (76.9%) 20 
0 (-) 0 i C-1 2.9%) 
ANA 2 (10.5%) 
(76.9%) 
3 9 
% 
(23.1%) 
11 (73.3%) 13 (37.1%) 
0 1t -1 ;r t1 
1; [yp’z”) 4 (26.7%) 
5.3%) ; ‘y:o/“’ 2 3 (25.7%) 5.7% 8 6
2% ;I tj 
t I 
2 7.7; 
CA50 5 (38.4%) 
i j 
1 (3.8%) 
aAMA, anti-mitochondrial antibodies > 1: 19; AM2, anti-M2, antibodies > 10 units/ml; ANA, antinuclear antibodies 
> 1: 10; ASM, anti-smooth muscle antibodies > 1: 10; CA50, monoclonal anti-CA50 antigen (RIA-gnostm, Behring, 
Mannheim, Germany) >normal level; oFI’, a-foetoprotein >normal level; PIII, procollagen III peptides >normal level. 
Table 5. Prevalence of immunological markers in 
patients with liver disease and in healthy blood donors 
Markersa 
PI11 
CA50 
a-Foetoprotein 
ANA 
AMA 
AM2 
ASM 
Patients with 
liver disease 
45184 (53.5%) 
72/84 (85.7%) 
22184 (26.2%) 
Blood donors 
51/81 (63.0%) 
3184 (3.5%) 
3181 (3.7%) 
8150 
1165 
(16.0%) 
(1.5%) 
aFor explanation, see footnote to Table 4. 
Table 6. Correlation between hepatocellular carcinoma and anti- 
hepatitis C antibody or hepatitis B surface antigen 
Total 
Anti-hepatitis’? 
Present Absent 
Hepatitis B surface 
antigenc 
Present Absent 
H;~s~~t+da~~maa 
Absent 
% 
l;’ (28.6%) l$(71,4%) 1; (64.3%) 4; (35.7%) 
Total 15 61 22 54 
“All patients with carcinoma had at least one marker of hepatitis B virus 
infection. 
bCorrelation between carcinoma nd anti-hepatitis C: x*=0.8455, P=O.36 
‘Correlation between carcinoma and hepatitis B surface antigen: 
y.2=10~42,P=O~O012. 
clinical or histological correlation with an autoimmune 
liver disease be found. Lw-Foetoprotein was significantly 
commoner in liver disease patients and children up to 5 
years old than in controls. 
Cirrhosis 
HBsAg was present in 47% of patients with cirrhosis, 
somewhat fewer than patients with HCC. Liver cirrhosis 
Table 7. Correlation between liver cirrhosis and hepatitis C virus or 
hepatitis B surface antigen 
Total 
Hepatitis C virus 
Present Absent 
Hepatitis,B surface 
anugen 
Present Absent 
19 8 (53%) 11 (18%) 9 (41%) 10 (19%) 
:z 
1; (47%) 5$(X2%) ;; (59%) ‘I; (81%) 
was associated in 42% with anti-HCV, indicating a com- 
bined infection with HBV and HCV (Table 7). 
Cirrhosis of the liver was correlated with both HCV in- 
fection (x2=8.0; P=O.O047) and the presence of HBsAg 
(x2=4.18; P=O.O41). 
All patients with liver cirrhosis, HCC, and chronic ac- 
tive or persistent hepatitis had at least one serum marker 
of HBV infection, and 53% (10) of the patients with liver 
cirrhosis had evidence of a combined infection with HBV 
and HCV, while 42% (8) of them were HBsAG negative. 
Five patients with HCC (38%) showed evidence of 
combined infection with HBV and HCV, and 5 had mar- 
kers of HBV infection only. 
Of the 7 patients with chronic active and the 3 with 
persistent hepatitis, 4 and 1, respectively, had markers of 
both HBV and HCV infection, while 3 and 2, respec- 
tively, had markers of HBV infection only. 
Discussion 
Although HAV and HBV had infected virtually every 
adult and a substantial number of the juvenile persons in 
our study, about one-third of the patients with liver dis- 
ease were also affected by some other hepatic disease 
(Table 1). 
Ultrasound proved to be particularly useful in the vis- 
ualization of focal hepatic lesions, although differentia- 
tion between amoebic liver abscess, HCC or malignant 
lymphoma can be very difficult (MISSALEK, 1992). Im- 
mediate puncture and aspiration can enable a rapid diag- 
nosis. Thus abdominal ultrasound is an efficient screen- 
ing diagnostic tool, while laparoscopy is even more 
helpful in making a definite diagnosis, confirmed by his- 
tology. 
Clinical signs of chronic liver disease, common among 
Caucasians, such as spider naevi, palmar erythema, loss 
of abdominal hair, and testicular atrophy are rarely seen 
in Black Africans (LEEVY et al., 1977). Variceal haemor- 
rhage, severe disorders of coagulation and portosystemic 
encephalopathy were not observed in this survey. Elev- 
ation of y-glutamyltransferase in serum was the most fre- 
quently abnormal liver function test. Nevertheless, its 
sensitivity of only 67% among liver disease patients is too 
low for screening purposes. Bleeding and coagulation 
time proved also to be of little help in evaluating diffuse 
parenchymatous liver disease. 
Although a substantial number of HBV infections 
probably occurs in the perinatal period, anti-HBc posi- 
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tivity steadily increases in the first 15 years of life (WHO 
1991). The source of infection during this period is not 
clear. Horizontal spread among small children, skin 
piercing as a traditional treatment or custom (scarifica- 
tion, circumcision), and early sexual activity may all play 
a role (NDUMBE, 1992; KAO et al., 1993; NDUMBE & 
SKALSKY, 1993): 
The HCV infection rate was comparatively low in the 
control uonulation, esneciallv in childhood, the time at 
which mos; blood transfusions are given for severe, mala- 
ria-associated anaemia. Concomitant HCV infection was, 
however, present in 18% of our patients with liver dis- 
ease. There was some evidence that the prevalence of 
anti-HCV antibodies increased with age: 3 of 35 subjects 
aged over 25 years had anti-HCV IgG, compared with 2 
of 73 of those aged 25 years or less (Table 4). This is in 
agreement with the marked prevalence of anti-HCV in 
persons over 40 years of age reported in a recent survey 
of another rural forest area in Cameroon (LOUIS et al., 
1994). 
Given the high rate of HBV infection in controls and 
the three-fold increases in prevalence of HCV infection 
in liver disease patients (a seven-fold increase in cir- 
rhosis) compared to controls, it may be speculated that 
HCV infection is of considerable imuortance in the de- 
velopment of chronic liver pathology.‘The mode of infec- 
tion with HCV in our population is uncertain. Blood 
transfusions do not seem to play a major role. 
There was a significant positive correlation between 
liver cirrhosis, HCC and HBsAg, and between liver cir- 
rhosis and anti-HCV, but only a weak positive correla- 
tion between HCV infection and HCC. 
A high frequency of positive autoantibodies, especially 
ANA (speckled pattern), has been described previously 
in regions endemic for falciparum malaria (BOONPUCK- 
NAVIC & EKAPANYAKUL, 1984; see also ACETI et al., 
1990). The autoantibodies. however. might also be mar- 
kers of an autoimmune process, triggered by a previous 
hepatitis virus infection (LENZI et al., 1991; VENTO et 
al., 1991). Histologically and clinically, however, we 
found neither chronic autoimmune hepatitis nor primary 
biliary cirrhosis in our survey, despite the rather high 
prevalence of ANA and AM2 autoantibodies among liver 
disease patients. 
The prevalence of a positive rapid plasma reagin test 
(RPR) for syphilis (17%) and the HCV prevalence of 6% 
in pregnant women (Table 3) were relatively high. Simi- 
lar results have been reported from the adult population 
of Yaounde, the capital of Cameroon, where the sera 
were tested by Treponema pallidurn haemagglutination 
(TPHA), a more specific antibody test for syphilis 
(NDUMBE, 1992), and for hepatitis C antibodies (MEN- 
CARINI, 1991). 
Whether there is a relationship between genital ulcer 
disease and HCV transmission, as there is for HIV-l 
transmission, needs further investigation. This was sug- 
gested by further observations from Yaounde, where the 
seroprevalence of HCV antibodies among prostitutes was 
about twice that of pregnant women (NDUMBE & SKAL- 
SKY, 1993) and by the fact that, in our cohort, the sero- 
prevalence of HCV antibodies among pregnant women 
with a positive RPR was about twice that observed in 
RPR negative pregnant women. 
Positive HIV-l status seemed not to have an influence 
on the expression of the different anti-hepatitis anti- 
bodies, especially HBsAg and anti-HCV, in our study. 
As HBV and HCV seem to play an important role in 
chronic liver disease in the area we investigated, the pre- 
valence of HBsAg (5.4%) and anti-HCV antibodies 
(6.1%) in pregnant women, with the risk of vertical 
transmission (THALER et al., 1992), is of epidemiological 
importance and supports the introduction of early vacci- 
nation against HBV and, in the future, if available, HCV 
in the Expanded Programme on Immunization (WHO, 
1991; NDUMBE & YENSHU, 1992). 
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